Dsc Advisors, L.P. Vyne Therapeutics Inc. Call Options Transaction History

Dsc Advisors, L.P.

  • $9.66 Million
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding VYNE

# of Institutions
2
Shares Held
36.5K
Call Options Held
0
Put Options Held
0
View Full List

About VYNE Therapeutics Inc.

VYNE Quotes by TradingView
  • Ticker VYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,005,600
  • Market Cap $170M
  • Description
  • VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...
More about VYNE
Track This Portfolio

Track Dsc Advisors, L.P. Portfolio

Follow Dsc Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dsc Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Dsc Advisors, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email